Impact of connecting tuberculosis directly observed therapy short-course with smoking cessation on health-related quality of life

Tobacco Induced Diseases

Aziah Ahmad Mahayiddin²  Syed Azhar Syed Sulaiman¹  Noorizan Abd Aziz⁵  Abdul Razak Muttalif²  Noorliza Mohamad Noordin³  Mohamad Haniki Nik Mohamed⁶  Ahmed Awaisu⁴ 

[1] School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Penang, Malaysia;Institute for Respiratory Medicine, 53000 Wilayah Persekutuan, Kuala Lumpur, Malaysia;Institute for Health Management, Ministry of Health, 59000 Kuala Lumpur, Malaysia;College of Pharmacy, Qatar University, P.O. Box 2713, Doha, Qatar;Faculty of Pharmacy, Universiti Technology Mara, 5600 Puncak Alam, Malaysia;Faculty of Pharmacy, International Islamic University Malaysia, 25200 Kuantan, Malaysia

关键词: Tuberculosis;    Smoking cessation intervention;    Quality of life;    Outcomes;    DOTS;   

Others  :  867058
DOI  :  10.1186/1617-9625-10-2

 received in 2011-11-03, accepted in 2012-02-28,  发布年份 2012

【 摘 要 】

Background

With evolving evidence of association between tuberculosis (TB) and tobacco smoking, recommendations for the inclusion of tobacco cessation interventions in TB care are becoming increasingly important and more widely disseminated. Connecting TB and tobacco cessation interventions has been strongly advocated as this may yield better outcomes. However, no study has documented the impact of such connection on health-related quality of life (HRQoL). The objective of this study was to document the impact of an integrated TB directly observed therapy short-course (DOTS) plus smoking cessation intervention (SCI) on HRQoL.

Methods

This was a multi-centered non-randomized controlled study involving 120 TB patients who were current smokers at the time of TB diagnosis in Malaysia. Patients were assigned to either of two groups: the usual TB-DOTS plus SCI (SCIDOTS group) or the usual TB-DOTS only (DOTS group). The effect of the novel strategy on HRQoL was measured using EQ-5D questionnaire. Two-way repeated measure ANOVA was used to examine the effects.

Results

When compared, participants who received the integrated intervention had a better HRQoL than those who received the usual TB care. The SCIDOTS group had a significantly greater increase in EQ-5D utility score than the DOTS group during 6 months follow-up (mean ± SD = 0.98 ± 0.08 vs. 0.91 ± 0.14, p = 0.006). Similarly, the mean scores for EQ-VAS showed a consistently similar trend as the EQ-5D indices, with the scores increasing over the course of TB treatment. Furthermore, for the EQ-VAS, there were significant main effects for group [F (1, 84) = 4.91, p = 0.029, η² = 0.06], time [F (2, 168) = 139.50, p = < 0.001, η² = 0.62] and group x time interaction [F (2, 168) = 13.89, p = < 0.001, η² = 0.14].

Conclusions

This study supports the evidence that an integrated TB-tobacco treatment strategy could potentially improve overall quality of life outcomes among TB patients who are smokers.

【 授权许可】

   
2012 Awaisu et al; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR: Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 2007, 167(4):335-342.
• [2]Lin HH, Ezzati M, Murray M: Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med 2007, 4(1):e20.
• [3]Slama K, Chiang CY, Enarson DA, Hassmiller K, Fanning A, Gupta P, Ray C: Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis 2007, 11(10):1049-1061.
• [4]Siddiqi K, Lee AC: An integrated approach to treat tobacco addiction in countries with high tuberculosis incidence. Trop Med Int Health 2009, 14(4):420-428.
• [5]Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG, Selvakumar N, Ganapathy S, Charles N, Rajamma J, et al.: Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis 2002, 6(9):780-788.
• [6]Chang KC, Leung CC, Tam CM: Risk factors for defaulting from anti-tuberculosis treatment under directly observed treatment in Hong Kong. Int J Tuberc Lung Dis 2004, 8(12):1492-1498.
• [7]Thomas A, Gopi PG, Santha T, Chandrasekaran V, Subramani R, Selvakumar N, Eusuff SI, Sadacharam K, Narayanan PR: Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India. Int J Tuberc Lung Dis 2005, 9(5):556-561.
• [8]d'Arc Lyra Batista J, de Fatima Pessoa Militao de Albuquerque M, De Alencar Ximenes RA, Rodrigues LC: Smoking increases the risk of relapse after successful tuberculosis treatment. Int J Epidemiol 2008, 37(4):841-851.
• [9]Yach D: Partnering for better lung health: improving tobacco and tuberculosis control. Int J Tuberc Lung Dis 2000, 4(8):693-697.
• [10]Schneider NK, Novotny TE: Addressing smoking cessation in tuberculosis control. Bull World Health Organ 2007, 85(10):820-821.
• [11]Novotny TE: Smoking cessation and tuberculosis: connecting the DOTS. Int J Tuberc Lung Dis 2008, 12(10):1103.
• [12]Awaisu A, Nik Mohamed MH, Abd Aziz N, Syed Sulaiman SA, Mohamad Noordin N, Muttalif AR, Ahmad Mahayiddin A: Tobacco use prevalence, knowledge, and attitudes among newly diagnosed tuberculosis patients in Penang State and Wilayah Persekutuan Kuala Lumpur, Malaysia. Tob Induc Dis 2010, 8(1):3. BioMed Central Full Text
• [13]Awaisu A, Mohamed MHN, Noordin NM, Aziz NA, Sulaiman SAS, Muttalif AR, Mahayiddin AA: Potential impact of a pilot training program on smoking cessation intervention for tuberculosis DOTS providers in Malaysia. J Public Health 2010, 18(3):279-288.
• [14]Slama K, Chiang CY, Enarson DA: Introducing brief advice in tuberculosis services. Int J Tuberc Lung Dis 2007, 11(5):496-499.
• [15]Slama K, Chiang CY, Enarson DA: Tobacco cessation and brief advice. Int J Tuberc Lung Dis 2007, 11(6):612-616.
• [16]El Sony A, Slama K, Salieh M, Elhaj H, Adam K, Hassan A, Enarson DA: Feasibility of brief tobacco cessation advice for tuberculosis patients: a study from Sudan. Int J Tuberc Lung Dis 2007, 11(2):150-155.
• [17]Slama K, Chiang CY, Enarson DA: An educational series about tobacco cessation interventions for tuberculosis patients: what about other patients? Int J Tuberc Lung Dis 2007, 11(3):244.
• [18]Slama K, Chiang CY, Enarson DA: Helping patients to stop smoking. Int J Tuberc Lung Dis 2007, 11(7):733-738.
• [19]Chiang CY, Slama K, Enarson DA: Tobacco use and tobacco control. Int J Tuberc Lung Dis 2007, 11(4):381-385.
• [20]Chiang CY, Slama K, Enarson DA: Associations between tobacco and tuberculosis. Int J Tuberc Lung Dis 2007, 11(3):258-262.
• [21]Enarson DA, Slama K, Chiang CY: Providing and monitoring quality service for smoking cessation in tuberculosis care. Int J Tuberc Lung Dis 2007, 11(8):838-847.
• [22]WHO, IUATLD: A WHO/The Union Monograph on TB and Tobacco Control. Joining Efforts to Control Two Related Global Epidemics. Geneva: World Health Organization & International Union Against Tuberculosis and Lung Disease; 2007.
• [23]Slama K, Chiang CY, Enarson DA (Eds): Tobacco Cessation Interventions for Tuberculosis Patients A Guide for Low-Income Countries. Paris: International Union Against Tuberculosis and Lung Disease; 2008.
• [24]WHO: Tuberculosis and Tobacco: a strong association. Geneva: World Health Organization; 2009.
• [25]Spilker B (Ed): Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven; 1996.
• [26]Dion MJ, Tousignant P, Bourbeau J, Menzies D, Schwartzman K: Feasibility and reliability of health-related quality of life measurements among tuberculosis patients. Qual Life Res 2004, 13(3):653-665.
• [27]DiClemente CC, Prochaska JO, Fairhurst SK, Velicer WF, Velasquez MM, Rossi JS: The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol 1991, 59(2):295-304.
• [28]Brooks R: EuroQol: the current state of play. Health Policy 1996, 37(1):53-72.
• [29]The EuroQol Group: EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990, 16(3):199-208.
• [30]Rabin R, de Charro F: EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001, 33(5):337-343.
• [31]Gudex C, Dolan P, Kind P, Williams A: Health state valuations from the general public using the visual analogue scale. Qual Life Res 1996, 5(6):521-531.
• [32]Dolan P, Gudex C, Kind P, Williams A: A Social Tariff for EuroQol: Results from a UK General Population Survey. York: The University of York; 1995.
• [33]Awaisu A, Nik Mohamed MH, Mohamad Noordin NM, Abd Aziz N, Syed Sulaiman SA, Muttalif RA, Ahmed Mahayiddin MA: The SCIDOTS Project: Evidence of benefits of an integrated tobacco cessation intervention in tuberculosis care on treatment outcomes. Subst Abuse Treat, Prev, Pol 2011, 6:26.
• [34]Lavigne M, Rocher I, Steensma C, Brassard P: The impact of smoking on adherence to treatment for latent tuberculosis infection. BMC Publ Health 2006, 6:66. BioMed Central Full Text
• [35]Guo N, Marra F, Marra CA: Measuring health-related quality of life in tuberculosis: a systematic review. Health Qual Life Outcomes 2009, 7:14. BioMed Central Full Text
• [36]Rajeswari R, Muniyandi M, Balasubramanian R, Narayanan PR: Perceptions of tuberculosis patients about their physical, mental and social well-being: a field report from south India. Soc Sci Med 2005, 60(8):1845-1853.
• [37]Marra CA, Marra F, Cox VC, Palepu A, Fitzgerald JM: Factors influencing quality of life in patients with active tuberculosis. Health Qual Life Outcomes 2004, 2:58. BioMed Central Full Text
• [38]Chamla D: The assessment of patients' health-related quality of life during tuberculosis treatment in Wuhan, China. Int J Tuberc Lung Dis 2004, 8(9):1100-1106.
• [39]Wang Y, Lii J, Lu F: Measuring and assessing the quality of life of patients with pulmonary tuberculosis. Zhonghua Jie He He Hu Xi Za Zhi 1998, 21(12):720-723.
• [40]Dhingra VK, Rajpal S: Health related quality of life (HRQL) scoring (DR-12 score) in tuberculosis-additional evaluative tool under DOTS. J Commun Dis 2005, 37(4):261-268.
• [41]American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington: American Psychiatric Association; 1994.
• [42]West R, Ussher M, Evans M, Rashid M: Assessing DSM-IV nicotine withdrawal symptoms: a comparison and evaluation of five different scales. Psychopharmacology (Berl) 2006, 184(3-4):619-627.